- 82k views
Metabolic syndrome in women with PCOS
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
About the Speaker
Dr. Krishna Kumari
Senior Consultant Gynecologist, Apollo Hospital, Hyderabad
Dr. M. Krishna Kumari is a distinguished Obstetrician and Gynecologist, currently serving as a Professor at Apollo Institute of Medical Sciences and Research. With an MBBS from Andhra University obtained in 1981 and an MD in Obstetrics and Gynecology from the same institution in 1985, where she was honored with the HM Lazarus Gold Medal, Dr. Kumari brings over 35 years of extensive clinical experience and two decades of dedicated teaching. Her expertise encompasses high-risk obstetrics, advanced gynecological procedures, and fertility regulation. Passionate about academics and professional development, Dr. Kumari is an active member of several prestigious organizations, including the Federation of Obstetric & Gynecological Societies of India (FOGSI), the Indian Society of Perinatology and Reproductive Biology (ISOPARB), and the Indian Menopausal Society (IMS). She also served as the President of the Obstetrics & Gynaecological Society of Hyderabad (OGSH) from 2017 to 2019. Dr. Kumari's commitment to her field and her contributions to both clinical practice and medical education make her a respected and influential figure in obstetrics and gynecology.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Krishna Kumari's Talks on Assimilate
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.